Management of Hepatocellular Carcinoma in Japan as a World-Leading Model.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

49 citing papers in PubMed, 2 syntheses or guidelines pooled it.

1. Comparison of abbreviated MRI and ultrasonography in the detection of early hepatocellular carcinoma: a meta-analysis.Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico · 2026
   Pooled it
2. [Guideline for stratified screening and surveillance of primary liver cancer(2020 Edition)].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2021
   Guideline
3. REFLECT-a phase 3 trial comparing efficacy and safety of lenvatinib to sorafenib for the treatment of unresectable hepatocellular carcinoma: an analysis of Japanese subset.Journal of gastroenterology · 2020
   Trial
4. Prevalence and Cure of Primary Liver Cancer in Italy by Histologic Type.Cancers · 2026
   Article
5. Assessment of Kupffer Cell-Specific Contrast-Enhanced Ultrasound for Characterization of Suspicious Malignant Focal Liver Lesions.The Indian journal of radiology & imaging · 2026
   Article
6. Metabotropic Glutamate Receptor 3 Expression During Liver Disease Progression: Association with Inflammation and Cell Viability in Hepatocellular Carcinoma.International journal of molecular sciences · 2026
   Article
7. Liver transplantation for HCC with macrovascular invasion: A systematic review and meta-analysis of observational studies.JHEP reports : innovation in hepatology · 2026
   Article
8. Lancet Commission 2025 Calls for Urgent Global Action: 60% of Liver Cancers Are Preventable.Liver cancer · 2025
   Article
9. Roadmap for HCC Surveillance and Management in the Asia Pacific.Cancers · 2025
   Article
10. Health inequalities in hepatocellular carcinoma surveillance, diagnosis, treatment, and survival in the United Kingdom: a scoping review.BJC reports · 2025
    Article
11. Optimizing Treatment Selection for Early Hepatocellular Carcinoma Based on Tumor Biology, Liver Function, and Patient Status.Journal of hepatocellular carcinoma · 2025
    Review
12. GALAD, or des-gamma-carboxy prothrombin compared with alpha-foetoprotein for the diagnosis of hepatocellular carcinoma in people with chronic liver disease.The Cochrane database of systematic reviews · 2024
    Article
13. Burden of liver cancer attributable to high fasting plasma glucose: a global analysis based on the global burden of disease study 2019.The journal of nutrition, health & aging · 2024
    Article
14. Early-stage hepatocellular carcinoma screening in patients with chronic hepatitis B in China: a cost-effectiveness analysis.Journal of comparative effectiveness research · 2024
    Article
15. Additional nodules detected using EOB-MRI in patients with resectable single hepatocellular carcinoma: an implication for active treatment strategy.Journal of liver cancer · 2024
    Article
16. Evaluation of the effectiveness of surgical resection and ablation for the treatment of early-stage hepatocellular carcinoma: A retrospective cohort study.Cancer reports (Hoboken, N.J.) · 2024
    Article
17. Ethnic differences in hepatocellular carcinoma prevalence and therapeutic outcomes.Cancer reports (Hoboken, N.J.) · 2023
    Review
18. Application of the Multi-Omics Liquid Biopsy Method M2P-HCC in Early Liver Cancer Screening for High-Risk Individuals with Hepatitis B-Related Liver Cancer.Diagnostics (Basel, Switzerland) · 2023
    Article
19. [Long-term trend analysis of liver cancer survival rate in Qidong region, Jiangsu Province, 1972-2019].Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology · 2023
    Article
20. Surveillance, Diagnosis, and Treatment Outcome of Hepatocellular Carcinoma in Japan: 2023 Update.Liver cancer · 2023
    Article

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

1 author.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.